Novolin 70-30 Innolet
"Miriam E. Tucker
Medscape Medical News
The U.S. Food and Drug Administration (FDA) will now require a "for single patient use only" warning on all multidose pen devices used for injectable diabetes medications.
Novolin 70/30 Innolet
No Information Provided.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 3/27/2009
Additional Novolin 70/30 Innolet Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find tips and advances in treatment.